Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 154 participants.

Also called NCT02029014

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 154 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02029014
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02029014. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
Intervention (Device)
LAA closure system
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02029014
Content hash
9a0ed773680d286ed9e8bb012a67990d8ce7de7468770e3e60f317a4b3c143b6